NYSEARCA:XLV

Health Care Select Sector SPDR Fund (XLV)

161.42
-2.32 (1.42%)
as of Jul 6, 2026, 3:33:57 pm Market Open.
87 watching
0
Investor Insights
star iconJul 6, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

The Health Care Select Sector SPDR Fund (XLV) is currently experiencing a mix of opinions among experts. While some believe that healthcare stocks can provide a short-term alpha opportunity, particularly in light of recent market shifts and emerging drugs like GLP-1s, others view the sector as a potential value trap due to its underperformance this year. Despite concerns over high valuations and potential inflation, experts suggest that healthcare remains a solid investment due to its insulation from interest rate volatility. One expert emphasizes the strategic focus on healthcare equipment and services as an alternative for those wary of political influences on pharmaceuticals. Overall, healthcare is anticipated to remain a buy for the long term, particularly as the sector may rebound in upcoming years.

consensus icon
Consensus
Buy
valuation icon
Valuation
Undervalued
review icon
Similar
IHI
COMMENT

Which ETF would you recommend to play the healthcare sector in the US? SPDR Health Care (XLV-N) generally does a pretty good job. If you don’t want to through the US, there is also BMO EqWt US HthCare Hedged CAD (ZUH-T) on the Canadian market.

PAST TOP PICK
(A Top Pick Oct 27/07. Down 11%.) This was basically a defensive play to the end of the year and was up at that time. Still a Buy.
TOP PICK
(SPDR Health Care E.T.F) Health care does well in the summer time, people like to take from aggressive positions and put money in defensive positions during holidays. Should sell at end of the year, before J.P Morgan health care conference takes place.
TOP PICK
Congress approved a Medicare bill that will put $500 billion into the health care sector.
Showing 61 to 64 of 64 entries